Literature DB >> 8666927

Distinct T cell receptor signaling requirements for perforin- or FasL-mediated cytotoxicity.

M T Esser1, B Krishnamurthy, V L Braciale.   

Abstract

A diverse array of signals are generated in a cytotoxic T lymphocyte (CTL) after the T cell receptor (TCR) engages the class I major histocompatibility complex (MHC) peptide complex. These signals result in a multitude of CTL effector functions, including cellular cytotoxicity, cell surface receptor expression, and cytokine secretion. We have examined signaling through the TCR in a wild type CD8+, MHC-restricted, antigen-specific CTL clone, 14-7, and its interleukin 2-dependent variant clone 14-7FD. We report here that 14-7FD is unable to kill via the perforin mechanism of killing, yet is able to kill via the Fas ligand/Fas mechanism and secrete interferon-gamma in an antigen-specific manner. 14-7FD has cytolytic granules that contain perforin and serine esterases, which are secreted after phorbol ester and Ca2+ ionophore treatment. Lastly, to investigate which TCR signaling requirements were operational in 14-7FD, we examined TCR-triggered intracellular Ca2+ mobilization in the two clones. After TCR engagement, 14-7FD failed to mobilize intracellular Ca2+, which may be the cause for its inability to trigger the perforin/granule exocytosis mechanism of killing. These results indicate that the signal transduction events that trigger perforin killing and the signaling requirements to induce FasL expression are distinct. We hypothesize that these two distinct TCR signal transduction requirements allow for separate activation of these two mechanisms of killing relating to their role in eradication of infected cells or regulation of immune responses.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8666927      PMCID: PMC2192501          DOI: 10.1084/jem.183.4.1697

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  64 in total

1.  Class I major histocompatibility complex-restricted cytolytic T lymphocytes recognize a limited number of sites on the influenza hemagglutinin.

Authors:  T J Braciale; M T Sweetser; L A Morrison; D J Kittlesen; V L Braciale
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

2.  Characterization of a monoclonal antibody which detects all murine alpha beta T cell receptors.

Authors:  R T Kubo; W Born; J W Kappler; P Marrack; M Pigeon
Journal:  J Immunol       Date:  1989-04-15       Impact factor: 5.422

3.  The role of Ca2+ in activation of mature cytotoxic T lymphocytes for lysis.

Authors:  H Ostergaard; W R Clark
Journal:  J Immunol       Date:  1987-12-01       Impact factor: 5.422

4.  Identification of a monoclonal antibody specific for a murine T3 polypeptide.

Authors:  O Leo; M Foo; D H Sachs; L E Samelson; J A Bluestone
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

Review 5.  Dimerization of cell surface receptors in signal transduction.

Authors:  C H Heldin
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

6.  Biochemical characterization of the inhibitory effect of CsA on cytolytic T lymphocyte effector functions.

Authors:  G Trenn; R Taffs; R Hohman; R Kincaid; E M Shevach; M Sitkovsky
Journal:  J Immunol       Date:  1989-06-01       Impact factor: 5.422

7.  Antigen receptor-triggered secretion of a trypsin-type esterase from cytotoxic T lymphocytes.

Authors:  H Takayama; G Trenn; W Humphrey; J A Bluestone; P A Henkart; M V Sitkovsky
Journal:  J Immunol       Date:  1987-01-15       Impact factor: 5.422

8.  The requirements for triggering of lysis by cytolytic T lymphocyte clones. II. Cyclosporin A inhibits TCR-mediated exocytosis by only selectively inhibits TCR-mediated lytic activity by cloned CTL.

Authors:  D W Lancki; B P Kaper; F W Fitch
Journal:  J Immunol       Date:  1989-01-15       Impact factor: 5.422

Review 9.  Fas and Fas ligand: lpr and gld mutations.

Authors:  S Nagata; T Suda
Journal:  Immunol Today       Date:  1995-01

10.  TCR/CD3 coupling to Fas-based cytotoxicity.

Authors:  F Vignaux; E Vivier; B Malissen; V Depraetere; S Nagata; P Golstein
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307

View more
  13 in total

Review 1.  Effector lymphocytes in islet cell autoimmunity.

Authors:  Pere Santamaria
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

Review 2.  The role of Fas-FasL in CD8+ T-cell-mediated insulin-dependent diabetes mellitus (IDDM).

Authors:  H T Kreuwel; L A Sherman
Journal:  J Clin Immunol       Date:  2001-01       Impact factor: 8.317

3.  A transgenic mouse model to analyze CD8(+) effector T cell differentiation in vivo.

Authors:  N Manjunath; P Shankar; B Stockton; P D Dubey; J Lieberman; U H von Andrian
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

4.  Regulation of IFN-gamma signaling is essential for the cytotoxic activity of CD8(+) T cells.

Authors:  G Z Tau; S N Cowan; J Weisburg; N S Braunstein; P B Rothman
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

5.  Fas ligand-mediated immune surveillance by T cells is essential for the control of spontaneous B cell lymphomas.

Authors:  Shoukat Afshar-Sterle; Dimitra Zotos; Nicholas J Bernard; Anna K Scherger; Lisa Rödling; Amber E Alsop; Jennifer Walker; Frederick Masson; Gabrielle T Belz; Lynn M Corcoran; Lorraine A O'Reilly; Andreas Strasser; Mark J Smyth; Ricky Johnstone; David M Tarlinton; Stephen L Nutt; Axel Kallies
Journal:  Nat Med       Date:  2014-02-02       Impact factor: 53.440

6.  Ca2+ signaling modulates cytolytic T lymphocyte effector functions.

Authors:  M T Esser; D M Haverstick; C L Fuller; C A Gullo; V L Braciale
Journal:  J Exp Med       Date:  1998-04-06       Impact factor: 14.307

7.  Role of perforin-mediated cell apoptosis in murine models of infusion-induced bone marrow failure.

Authors:  Annahita K Sarcon; Marie J Desierto; Wenjun Zhou; Valeria Visconte; Federica Gibellini; Jichun Chen; Neal S Young
Journal:  Exp Hematol       Date:  2009-02-12       Impact factor: 3.084

8.  Activation of human intraepithelial lymphocytes reduces CD3 expression.

Authors:  E C Ebert
Journal:  Clin Exp Immunol       Date:  2003-06       Impact factor: 4.330

9.  Antigen presented by tumors in vivo determines the nature of CD8+ T-cell cytotoxicity.

Authors:  Anil Shanker; Alan D Brooks; Kristen M Jacobsen; John W Wine; Robert H Wiltrout; Hideo Yagita; Thomas J Sayers
Journal:  Cancer Res       Date:  2009-08-04       Impact factor: 12.701

10.  Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2.

Authors:  Yi-Hao Chan; Siew-Wai Fong; Chek-Meng Poh; Guillaume Carissimo; Nicholas Kim-Wah Yeo; Siti Naqiah Amrun; Yun Shan Goh; Jackwee Lim; Weili Xu; Rhonda Sin-Ling Chee; Anthony Torres-Ruesta; Cheryl Yi-Pin Lee; Matthew Zirui Tay; Zi Wei Chang; Wen-Hsin Lee; Bei Wang; Seow-Yen Tan; Shirin Kalimuddin; Barnaby Edward Young; Yee-Sin Leo; Cheng-I Wang; Bernett Lee; Olaf Rötzschke; David Chien Lye; Laurent Renia; Lisa F P Ng
Journal:  EMBO Mol Med       Date:  2021-05-27       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.